LAMs are myeloid-lineage cells derived from circulating monocytes, which are recruited into the LME by tumor, and EBV-derived factors such as CCL2, colony-stimulating factor 1 (CSF-1), and inflammatory cytokines [21,49]. The gene discussed is CSF1; the disease is neoplasm.